Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence

The endoribonuclease RNase-L requires 2’,5’-linked oligoadenylates for activation, and mediates antiviral and antiproliferative activities. We previously determined that RNase-L activation induces senescence; to determine potential mechanisms underlying this activity, we used microarrays to identify RNase-L-regulated mRNAs. RNase-L activation affected affected a finite number of transcripts, and thus does not lead to a global change in mRNA turnover. The largest classes of downregulated transcripts, that represent candidate RNase-L substrates, function in protein biosynthesis, metabolism, and proliferation. Among these, mRNAs encoding ribosomal proteins (RPs) were particularly enriched. The reduced levels of four RP mRNAs corresponded with a decrease in their half lives and a physical association with an RNase-L- ribonucleoprotein (RNP) complex in cells, suggesting that they represent authentic RNase-L substrates. Sequence and structural analysis of the downregulated mRNAs identified a putative RNase-L target motif that was used for the in silico identification of a novel RNase-L-RNP-interacting transcript. The downregulation of RP mRNAs corresponded with a marked reduction in protein translation, consistent with the roles of RP proteins in ribosome function. Our data support a model in which the RNase-L-mediated degradation of RP mRNAs inhibits translation, and may contribute to its antiproliferative, senescence inducing, and tumor suppressor activities.

[1]  M. Gorospe,et al.  Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence , 2008, Biological chemistry.

[2]  R. Silverman,et al.  Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. , 2007, Virus research.

[3]  R. Silverman,et al.  A scientific journey through the 2-5A/RNase L system. , 2007, Cytokine & growth factor reviews.

[4]  J. Keene RNA regulons: coordination of post-transcriptional events , 2007, Nature Reviews Genetics.

[5]  David Bryant,et al.  DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..

[6]  R. Silverman,et al.  Small-molecule activators of RNase L with broad-spectrum antiviral activity , 2007, Proceedings of the National Academy of Sciences.

[7]  R. Silverman,et al.  Role of 2-5A-dependent RNase-L in senescence and longevity , 2007, Oncogene.

[8]  G. M. Wilson,et al.  Post-transcriptional Regulation of RNase-L Expression Is Mediated by the 3′-Untranslated Region of Its mRNA* , 2007, Journal of Biological Chemistry.

[9]  R. Silverman,et al.  A Phylogenetically Conserved RNA Structure in the Poliovirus Open Reading Frame Inhibits the Antiviral Endoribonuclease RNase L , 2007, Journal of Virology.

[10]  J. Derisi,et al.  An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors , 2007, Proceedings of the National Academy of Sciences.

[11]  Arul M. Chinnaiyan,et al.  Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells , 2006, Nucleic acids research.

[12]  I. Grummt,et al.  Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases , 2006, Oncogene.

[13]  Roger J. Davis,et al.  Control of cellular senescence by CPEB. , 2006, Genes & development.

[14]  J. Derisi,et al.  Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant , 2006, PLoS pathogens.

[15]  B. Williams,et al.  A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Bushell,et al.  TOPs and their regulation. , 2006, Biochemical Society transactions.

[17]  Geppino Falco,et al.  Identification and Functional Outcome of mRNAs Associated with RNA-Binding Protein TIA-1 , 2005, Molecular and Cellular Biology.

[18]  S. Peltz,et al.  A newly discovered function for RNase L in regulating translation termination , 2005, Nature Structural &Molecular Biology.

[19]  I. Kerr,et al.  Synthesis, characterization and properties of ppp(A2'p)nApCp and related high-specific-activity 32P-labelled derivatives of ppp(A2'p)nA. , 2005, European journal of biochemistry.

[20]  J. Campisi Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[21]  K. Chandrasekaran,et al.  RNase-L regulates the stability of mitochondrial DNA-encoded mRNAs in mouse embryo fibroblasts. , 2004, Biochemical and biophysical research communications.

[22]  M. Yamashita,et al.  Identification of 2′-Phosphodiesterase, Which Plays a Role in the 2-5A System Regulated by Interferon* , 2004, Journal of Biological Chemistry.

[23]  P. Pandolfi,et al.  The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.

[24]  J. Shay,et al.  Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.

[25]  M. Gorospe,et al.  Identification of a target RNA motif for RNA-binding protein HuR. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Silverman,et al.  Proteasome-mediated degradation of RNase L in response to phorbol-12-myristate-13-acetate (PMA) treatment of mouse L929 cells. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[27]  B. Williams,et al.  RNase L Mediates Transient Control of the Interferon Response through Modulation of the Double-stranded RNA-dependent Protein Kinase PKR* , 2003, Journal of Biological Chemistry.

[28]  K. Becker,et al.  Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.

[29]  P. Walsh,et al.  RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. , 2003, The Journal of urology.

[30]  C. Schmitt Senescence, apoptosis and therapy — cutting the lifelines of cancer , 2003, Nature Reviews Cancer.

[31]  K. Klinger,et al.  Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 , 2002, Nature Genetics.

[32]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[33]  C. Bisbal,et al.  The 2′-5′ Oligoadenylate/RNase L/RNase L Inhibitor Pathway Regulates Both MyoD mRNA Stability and Muscle Cell Differentiation , 2000, Molecular and Cellular Biology.

[34]  Xiao-Ling Li,et al.  RNase L Mediates the Antiviral Effect of Interferon through a Selective Reduction in Viral RNA during Encephalomyocarditis Virus Infection , 1998, Journal of Virology.

[35]  R. Silverman,et al.  Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.

[36]  C. Rivas,et al.  Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. , 1997, Virology.

[37]  M. Dalakas,et al.  A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 2–5A System , 1997, The Journal of experimental medicine.

[38]  R. Silverman,et al.  2-5A-dependent RNase Molecules Dimerize during Activation by 2-5A (*) , 1995, The Journal of Biological Chemistry.

[39]  J. Campisi,et al.  Identification of a transcript that is down-regulated in senescent human fibroblasts. Cloning, sequence analysis, and regulation of the human L7 ribosomal protein gene. , 1993, The Journal of biological chemistry.

[40]  R. Silverman,et al.  A dominant negative mutant of 2‐5A‐dependent RNase suppresses antiproliferative and antiviral effects of interferon. , 1993, The EMBO journal.

[41]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[42]  R. Silverman,et al.  Purification and analysis of murine 2-5A-dependent RNase. , 1988, The Journal of biological chemistry.

[43]  A. De Benedetti,et al.  Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease , 1984, Journal of virology.

[44]  Silverman,et al.  rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells , 1983, Journal of virology.

[45]  P. Lengyel,et al.  Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease. , 1981, Science.

[46]  I. Kerr,et al.  Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. , 1981, Nucleic acids research.

[47]  T. Nilsen,et al.  Analogs of (2'-5')oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells. , 1981, The Journal of biological chemistry.

[48]  J. Skehel,et al.  Interferon action—sequence specificity of the ppp(A2′p)nA-dependent ribonuclease , 1981, Nature.

[49]  I. Kerr,et al.  Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells , 1979, Nature.

[50]  T. Nilsen,et al.  Mechanism for discrimination between viral and host mRNA in interferon-treated cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Silverman,et al.  Tumour suppressor function of RNase L in a mouse model. , 2007, European journal of cancer.